The Latin America, Middle East and Africa Hemostats Market would witness market growth of 8.3% CAGR during the forecast period (2022-2028).
The primary cause of illness and mortality in industrialized countries is atherosclerotic plaque rupture, which results in thrombosis of the coronary and cerebral arteries. The molecular characterization of vascular and hemostatic variables has made significant strides over the last two decades. These developments improve the knowledge of the processes involved in the formation of hemostatic and thrombotic plugs.
It is essential that the surgical team employ solid clinical judgement when choosing an agent or combination of agents to maximize patient outcomes because timely delivery is a key component in attaining hemostasis. The size and shape of the wound, the severity of the bleeding, the agent's effectiveness, any potential side effects, the application method, user friendliness, timing requirements, & storage needs are all important factors to take into consideration when choosing a hemostat.
If residual bleeding continues after the use of conventional methods for hemorrhage control during surgical operations, a wide range of hemostats are available as a supplemental strategy to enhance hemostasis. Some are referred to as "active agents" because they include thrombin and fibrinogen and actively contribute to the formation of a fibrin clot at the conclusion of the coagulation cascade, whereas others need the coagulation system to function properly.
Due to Dubai's rapid urban expansion and ever-increasing population, a huge influx of medical tourists who rely on Dubai's top-notch hospitals and specialty clinics for their treatments has raised the demand for quality health services. Dubai is a major hub for the healthcare business, ready to serve not just the local market but also larger regional demand owing to its high-tech medical infrastructure and a growing number of public and private healthcare organizations. Currently, among the most popular medical specializations for tourists seeking treatment in Dubai are sports medicine, orthopedics, dermatology & skin care, dentistry, and reproductive treatment.
The Brazil market dominated the LAMEA Hemostats Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $64.2 million by 2028. The Argentina market is experiencing a CAGR of 8.9% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 8% during (2022 - 2028).
Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Others. Based on Formulation, the market is segmented into Matrix & Gel, Sheet & Pad, Powder, Sponge, and Others. Based on Type, the market is segmented into Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Hemostats Market is Predict to reach $3.7 Billion by 2028, at a CAGR of 5.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, Teleflex, Inc., Medtronic PLC, Johnson & Johnson, Pfizer, Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation, and Artivion, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
By Formulation
- Matrix & Gel
- Sheet & Pad
- Powder
- Sponge
- Others
By Type
- Thrombin Based
- Combination
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Baxter International, Inc.
- B. Braun Melsungen AG
- Teleflex, Inc.
- Medtronic PLC
- Johnson & Johnson
- Pfizer, Inc.
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- Artivion, Inc.
TABLE 1 LAMEA Hemostats Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Hemostats Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 4 LAMEA Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 5 LAMEA Orthopedic Surgery Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Orthopedic Surgery Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA General Surgery Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA General Surgery Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Neurological Surgery Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Neurological Surgery Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Cardiovascular Surgery Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Cardiovascular Surgery Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Reconstructive Surgery Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Reconstructive Surgery Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Gynecological Surgery Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Gynecological Surgery Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 20 LAMEA Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 21 LAMEA Matrix & Gel Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Matrix & Gel Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Sheet & Pad Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Sheet & Pad Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Powder Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Powder Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Sponge Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Sponge Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 32 LAMEA Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 33 LAMEA Thrombin Based Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Thrombin Based Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Combination Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Combination Market by Country, 2022 - 2028, USD Million
TABLE 37 LAMEA Oxidized Regenerated Cellulose Based Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Oxidized Regenerated Cellulose Based Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Gelatin Based Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Gelatin Based Market by Country, 2022 - 2028, USD Million
TABLE 41 LAMEA Collagen Based Market by Country, 2018 - 2021, USD Million
TABLE 42 LAMEA Collagen Based Market by Country, 2022 - 2028, USD Million
TABLE 43 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 44 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 45 LAMEA Hemostats Market by Country, 2018 - 2021, USD Million
TABLE 46 LAMEA Hemostats Market by Country, 2022 - 2028, USD Million
TABLE 47 Brazil Hemostats Market, 2018 - 2021, USD Million
TABLE 48 Brazil Hemostats Market, 2022 - 2028, USD Million
TABLE 49 Brazil Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 50 Brazil Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 51 Brazil Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 52 Brazil Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 53 Brazil Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 54 Brazil Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 55 Argentina Hemostats Market, 2018 - 2021, USD Million
TABLE 56 Argentina Hemostats Market, 2022 - 2028, USD Million
TABLE 57 Argentina Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 58 Argentina Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 59 Argentina Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 60 Argentina Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 61 Argentina Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 62 Argentina Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 63 UAE Hemostats Market, 2018 - 2021, USD Million
TABLE 64 UAE Hemostats Market, 2022 - 2028, USD Million
TABLE 65 UAE Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 66 UAE Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 67 UAE Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 68 UAE Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 69 UAE Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 70 UAE Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 71 Saudi Arabia Hemostats Market, 2018 - 2021, USD Million
TABLE 72 Saudi Arabia Hemostats Market, 2022 - 2028, USD Million
TABLE 73 Saudi Arabia Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 74 Saudi Arabia Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 75 Saudi Arabia Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 76 Saudi Arabia Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 77 Saudi Arabia Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 78 Saudi Arabia Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 79 South Africa Hemostats Market, 2018 - 2021, USD Million
TABLE 80 South Africa Hemostats Market, 2022 - 2028, USD Million
TABLE 81 South Africa Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 82 South Africa Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 83 South Africa Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 84 South Africa Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 85 South Africa Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 86 South Africa Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 87 Nigeria Hemostats Market, 2018 - 2021, USD Million
TABLE 88 Nigeria Hemostats Market, 2022 - 2028, USD Million
TABLE 89 Nigeria Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 90 Nigeria Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 91 Nigeria Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 92 Nigeria Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 93 Nigeria Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 94 Nigeria Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 95 Rest of LAMEA Hemostats Market, 2018 - 2021, USD Million
TABLE 96 Rest of LAMEA Hemostats Market, 2022 - 2028, USD Million
TABLE 97 Rest of LAMEA Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 98 Rest of LAMEA Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 99 Rest of LAMEA Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 100 Rest of LAMEA Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 101 Rest of LAMEA Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 102 Rest of LAMEA Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 103 Key information – Becton, Dickinson and Company
TABLE 104 Key Information – Baxter International, Inc.
TABLE 105 key Information – B. Braun Melsungen AG
TABLE 106 key Information – Teleflex, Inc.
TABLE 107 Key Information – Medtronic PLC
TABLE 108 Key Information – Johnson & Johnson
TABLE 109 Key Information – Pfizer, Inc.
TABLE 110 key Information – Stryker Corporation
TABLE 111 Key Information – Integra LifeSciences Holdings Corporation
TABLE 112 Key Information – Artivion, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Becton, Dickinson and company
FIG 3 Swot analysis: Medtronic plc
FIG 4 SWOT analysis: Johnson & Johnson